Location History:
- Ozone Park, NJ (US) (2003)
- Ozone Park, NY (US) (2003)
Company Filing History:
Years Active: 2003
Title: Vitaly Falevich: Innovator in Electrically Assisted Drug Delivery
Introduction
Vitaly Falevich is a notable inventor based in Ozone Park, NJ (US), recognized for his contributions to the field of electrically assisted drug delivery. With a total of two patents to his name, Falevich has made significant strides in developing innovative methods and devices that enhance drug delivery systems.
Latest Patents
Falevich's latest patents include a method for manufacturing electrodes for electrically assisted drug delivery. This method involves loading electrode-corroding ingredients into an un-loaded donor gel reservoir, which is contrary to conventional practices. The method utilizes a salt, such as sodium chloride or an organic salt, to improve the efficiency of the drug delivery system. Another significant patent is for a shelf storage stable iontophoresis reservoir-electrode. This invention features a hydrophilic reservoir that is in electrically conductive relation to the electrode, designed to eliminate concentration gradients of the salt with respect to the electrode. The polymeric material used in this invention ensures that minimal residue remains on the patient's skin upon removal, enhancing user experience and effectiveness.
Career Highlights
Falevich is currently associated with Vyteris, Inc., where he continues to innovate in the field of drug delivery technologies. His work has been instrumental in advancing the capabilities of iontophoretic delivery devices, making them more efficient and user-friendly.
Collaborations
Some of Falevich's notable coworkers include Preston Keusch and Uday K Jain, who contribute to the collaborative environment at Vyteris, Inc. Their combined expertise fosters innovation and drives the development of cutting-edge technologies in the medical field.
Conclusion
Vitaly Falevich's contributions to electrically assisted drug delivery systems highlight his role as a key innovator in the medical technology sector. His patents reflect a commitment to improving patient care through advanced drug delivery methods.